SUBSCRIBE
SUBSCRIBE

Chelsea Weidman Burke

Business
Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier
One company working towards an ARDS treatment is Athersys, a biotech company focusing on regenerative medicine therapies for diseases with significant unmet need.
September 15, 2020
 · 
11 min read
 · 
Chelsea Weidman Burke
RNA Binding Proteins
Biotech Beach
Untangling the Body’s Smart Sensors: What RNA Binding Proteins Can Tell Us About Gene Regulation
Can you imagine organizing more than 10 terabytes of data into a useful network of information? But researchers are trying to do just that by finding RNA Binding Proteins.
September 11, 2020
 · 
7 min read
 · 
Chelsea Weidman Burke
Business
Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding
Earlier this year, BioSpace tallied up the hottest U.S. biotech start-ups in their NextGen Bio Class of 2020 – Anthos Therapeutics was ranked #2.
September 10, 2020
 · 
8 min read
 · 
Chelsea Weidman Burke
Business
Can High Blood Sugar (hyperglycemia) Haunt People with Diabetes Even After it is Under Control?
In people with diabetes, periods of high blood sugar (hyperglycemia) can negatively impact their health years later, even if they get their blood sugar under control.
September 9, 2020
 · 
8 min read
 · 
Chelsea Weidman Burke
Business
Equipping the Immune System to Fight Against COVID-19
When someone gets sick with COVID-19, there is a lag in an efficient immune response, giving the virus time to do significant damage before the immune system can reign in the infection.
August 27, 2020
 · 
9 min read
 · 
Chelsea Weidman Burke
Business
Detecting Coronavirus’ Structural Fingerprint as a Screening Method
Lasers aren’t just for directing presentations, playing tag or annoying cats. They can also serve as virus hunters.
August 26, 2020
 · 
6 min read
 · 
Chelsea Weidman Burke
Drug Development
Viaskin™ Peanut’s Long-Term Phase III Updates and What the FDA Has to Say About Them
DBV Technologies aims to fill the peanut allergy treatment gap, especially for highly allergic children, with their low dose epicutaneous immunotherapy (EPIT) patch Viaskin™ Peanut.
August 14, 2020
 · 
14 min read
 · 
Chelsea Weidman Burke
Drug Development
Restoring Cellular Power Outages: A New Drug to Treat Mitochondrial Diseases
A small biotech company is aiming to recharge tired cells, giving mitochondrial disease patients new hope of a disease-specific treatment.
August 6, 2020
 · 
6 min read
 · 
Chelsea Weidman Burke
Drug Development
How an AI-Powered Phone App is Helping Participants During Clinical Trials
AiCure’s phone app helps clinical trials keep tabs on which participants have taken their medications correctly and which have not. By analyzing videos the app takes, they can also spot who is intentionally not taking their pills, known as intentional nonadherence.
July 30, 2020
 · 
6 min read
 · 
Chelsea Weidman Burke
Business
The Time for DMD Gene Therapy is Now: A Chat with the MDA
After almost 15 years since the first gene therapy trial for Duchenne muscular dystrophy (DMD) began, the dream of a DMD gene therapy drug is getting closer to a reality.
July 29, 2020
 · 
11 min read
 · 
Chelsea Weidman Burke
Biotech Bay
Another COVID-19 Vaccine Joins the Race – This Time, it’s a Live, Weakened Virus
Another COVID-19 vaccine candidate recently entered the races. The difference – this one is a live attenuated (weakened) virus expressing the coronavirus’s signature spike protein on its surface. And it’s delivered nasally, not a shot.
July 20, 2020
 · 
8 min read
 · 
Chelsea Weidman Burke
Business
Developing an ‘Inverse Vaccine’ for Type 1 Diabetes
What do you get when you mix certain immune cells with vitamin D and a disease-provoking molecule? An innovative new vaccine for type 1 diabetes.
July 14, 2020
 · 
6 min read
 · 
Chelsea Weidman Burke
Business
A ‘Pan-Viral’ Vaccine Designed to Protect the Elderly from Known, and Unknown, Viruses
What if you could get one vaccine that protects you against a wide spectrum of viruses, even viruses we haven’t discovered yet?
July 8, 2020
 · 
10 min read
 · 
Chelsea Weidman Burke
Business
MyoKardia: The Precision Cardiac Medicine Company with Diversity and Inclusion at its Heart
Putting your employees and company culture first keeps the focus on inclusion and innovation, giving the company an incredible competitive advantage.
July 7, 2020
 · 
13 min read
 · 
Chelsea Weidman Burke
New researches on probable cure for HIV approachin
Drug Development
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
To learn more about ImmunityBio’s HIV drug candidate, BioSpace spoke to Dr. Whitney and Jeffrey Safrit, PhD, director of Cell-Mediated Therapies in Virology at NantKwest.
May 21, 2020
 · 
9 min read
 · 
Chelsea Weidman Burke
Load More